← Leaderboards
Daniel Sigg
Nanocor Therapeutics, Inc.
$3,811,493
Attributed
$3,811,493
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2012–18$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,811,493 · 4
By mechanism
R44$2,721,470 · 1
R43$1,090,023 · 3
Top collaborators
No co-investigators on record.
Most similar at Nanocor Therapeutics, Inc.
Same institution · by research overlap
- Maritza C McIntyre$2,623,563
Others in their field
Top investigators on “Small Business Innovation Research Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Praduman Jain · Vignet, Inc.$106,968,877
- Stephen Lev Hoffman · Sanaria, Inc.$37,771,680
- Eric Baer · Case Western Reserve University$37,136,000
- John B Buse · University Of North Carolina Chapel Hill$23,865,764
- Gary Fanger · Rise Therapeutics, Llc$23,463,293
Research focus
Small Business Innovation Research GrantProceduresInstrumentDesignDevicesPrototypeSafetyQualifyingCardiacReportingStructureBaseCommercializationHeartTechnologyCessation Of LifeCerebrumChargeAblationArrhythmiaCerebrovascularChronicBloodCanis Familiaris
Grant awards (5)
Soft Tissue Tension Sensor$224,640
R43 · FY2018 · DE · contact PI
Anticoagulum Cardiac RF Ablation Catheter (Direct Phase II)$1,501,246
R44 · FY2016 · HL · contact PI
Anticoagulum Cardiac RF Ablation Catheter (Direct Phase II)$1,220,224
R44 · FY2015 · HL · contact PI
Orthopedic Tissue Tension Sensor$225,000
R43 · FY2014 · AR · contact PI
Gene Based Therapy for Congestive Heart Failure$640,383
R43 · FY2012 · HL · contact PI